The Bremen-based space group OHB has found itself in an uncomfortable position familiar to many mid-cap stocks: the operational story keeps improving, yet the share price keeps sliding. The latest session marked the fifth consecutive trading day of losses, leaving the stock as the SDAX’s worst performer on Monday and trading at around €196 — a notable retreat from the previous close of €201.50 and a long way from the record highs touched in May.
That May peak coincided with the SpaceX initial public offering, which lifted the entire space sector on a wave of enthusiasm. The problem now is that the tide has gone out for the whole industry. SpaceX itself has slipped below its own issue price since its mid-June peak, and OHB is being dragged along in what looks increasingly like a sector-wide correction rather than a company-specific problem.
A Pipeline That Keeps Growing
The disconnect between the share price and the underlying business is striking. In August, OHB posted first-half results showing total output of €627.9 million, with adjusted EBITDA of €60 million — up more than 30 percent year on year. Management reaffirmed its full-year guidance of €1.4 billion in total output at an EBITDA margin of 10.5 to 11 percent, and the order book stands at a record level, with the pipeline of potential new projects reportedly worth around €20 billion.
The headline catalyst remains the Iris² programme, for which OHB is to build 18 medium-Earth-orbit satellites in a deal worth roughly €1 billion — a contract that secures revenue visibility into 2029. There have been other wins too: OHB Italia received an order from the Italian space agency ASI in late July for the second generation of the PRISMA mission, a project running until the end of 2031. And the company’s promotion to the SDAX in mid-August underlined its growing weight in Germany’s small-cap segment.
The Capital-Raising Hangover
Yet the market has chosen to focus on other things. One overhang is the dilutive capital increase completed over the summer, which saw 1.7 million new shares issued at €300 apiece, raising around €484 million. That injection of fresh capital strengthened the balance sheet but significantly diluted existing shareholders, and the question of whether the market has fully digested that dilution remains open.
Adding to the pressure, KKR’s Orchid Lux HoldCo vehicle sold 1.39 million existing shares in connection with the capital raise — a move some market participants read as profit-taking by a major investor following a strong rally over the past twelve months.
A Technical Picture That Looks Bruised
The charts offer little comfort. The stock is trading roughly 27 percent below its 50-day moving average, a clear sign that the short-term trend is pointing firmly downwards. The share price has also drifted well away from its medium-term average lines in recent weeks, suggesting the downtrend is intact rather than exhausted.
Should investors sell immediately? Or is it worth buying OHB SE?
The stock’s annualised volatility of 63 percent underscores how abruptly the shares can move in either direction. And a worrying pattern has emerged: positive news — the SDAX promotion, the Iris² contract — has provided only brief bounces before the gains were quickly given back. Buyers have been notably absent, with good news apparently failing to stick.
What Could Turn the Tide
For the bulls, the valuation argument is straightforward. Several analysts published initial price targets between €250 and €360 in early August, well above current levels. Jefferies’ Chloe Lemarie reaffirmed a “Buy” rating with a €280 target in early August after reviewing the second-quarter numbers — though that call predates the recent slide.
The near-term calendar offers potential catalysts. OHB is scheduled to appear at the Jefferies Industrials Conference on September 9-10 and the Berenberg & Goldman Sachs German Corporate Conference on September 21, where management has the chance to make its growth case to institutional investors. The next hard data point comes with the third-quarter report on November 12.
The bearish camp, meanwhile, points to the sector’s continued dependence on SpaceX sentiment. As long as the wider space industry remains under pressure, OHB is likely to be dragged along regardless of its own contract wins. The two stocks have moved closely in tandem since the spring, and that correlation shows little sign of breaking.
The Bottom Line
The fundamental case for OHB remains intact as long as the order book keeps growing and guidance holds. The current weakness can be framed as a valuation correction following the sector’s post-IPO euphoria rather than an operational crisis. But if guidance were to slip — through delays on major programmes like Iris² or PRISMA — the narrative itself would deteriorate, and the downward pressure would be confirmed.
For now, the market is treating OHB’s achievements with a distinct lack of enthusiasm. Whether that changes depends on whether the sector’s sentiment stabilises and whether positive news finally starts to stick. Until then, the stock remains hostage to a broader space-sector mood that has turned decidedly cooler.
Ad
OHB SE Stock: Buy or Sell?! New OHB SE Analysis from August 25 delivers the answer:
The latest OHB SE figures speak for themselves: Urgent action needed for OHB SE investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 25.
OHB SE: Buy or sell? Read more here...
